AGTI - Agiliti, Inc.
NYSE
->
Healthcare
->
Health Information Services
Minneapolis,
United States
Type: Equity
AGTI price evolution
AGTI
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $20.04 | $30.39 | $9.21 | $14.45 |
| Short term investments | ||||
| Net receivables | $215.68 | $212.99 | $220.27 | $222.85 |
| Inventory | $74.48 | $79.19 | $79.15 | $73.58 |
| Total current assets | $337.74 | $344.2 | $328.82 | $333.64 |
| Long term investments | ||||
| Property, plant & equipment | $370.84 | $361.02 | $364.85 | $357.18 |
| Goodwill & intangible assets | $1669.43 | $1689.26 | $1709.85 | $1730.47 |
| Total noncurrent assets | $2061.2 | $2074.93 | $2098.69 | $2109.77 |
| Total investments | ||||
| Total assets | $2398.94 | $2419.12 | $2427.51 | $2443.41 |
| Current liabilities | ||||
| Accounts payable | $58.52 | $71 | $70.33 | $69.43 |
| Deferred revenue | ||||
| Short long term debt | $44.07 | $43.99 | $41.77 | $42.23 |
| Total current liabilities | $196.61 | $211.7 | $180.69 | $197.16 |
| Long term debt | $1124.83 | $1122.51 | $1148.29 | $1148.55 |
| Total noncurrent liabilities | $1261.51 | $1262.94 | $1292.4 | $1299.05 |
| Total debt | $1168.9 | $1166.5 | $1190.07 | $1190.78 |
| Total liabilities | $1458.12 | $1474.64 | $1473.1 | $1496.21 |
| Shareholders' equity | ||||
| Retained earnings | -$33.7 | -$27.99 | -$15.29 | -$11.26 |
| Other shareholder equity | $2.5 | $6.36 | $5.5 | $3.34 |
| Total shareholder equity | $940.56 | $944.24 | $954.19 | $947.02 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $20.04 | $5.58 | $74.33 | $206.5 |
| Short term investments | ||||
| Net receivables | $215.68 | $207.75 | $209.31 | $154.63 |
| Inventory | $74.48 | $70.13 | $55.31 | $27.06 |
| Total current assets | $337.74 | $316.31 | $357.88 | $402.37 |
| Long term investments | ||||
| Property, plant & equipment | $370.84 | $353.93 | $339.05 | $265.63 |
| Goodwill & intangible assets | $1669.43 | $1751.13 | $1786.28 | $1219.21 |
| Total noncurrent assets | $2061.2 | $2127.79 | $2157.86 | $1500.99 |
| Total investments | ||||
| Total assets | $2398.94 | $2444.11 | $2515.75 | $1903.36 |
| Current liabilities | ||||
| Accounts payable | $58.52 | $59.16 | $53.85 | $37.22 |
| Deferred revenue | $5.81 | |||
| Short long term debt | $44.07 | $41.36 | $40.36 | $30.2 |
| Total current liabilities | $196.61 | $197.38 | $208.53 | $159.53 |
| Long term debt | $1124.83 | $1077.29 | $1238.21 | $1185.34 |
| Total noncurrent liabilities | $1261.51 | $1300.4 | $1411.14 | $1301.88 |
| Total debt | $1168.9 | $1185.98 | $1278.57 | $1215.54 |
| Total liabilities | $1458.12 | $1497.98 | $1619.67 | $1461.41 |
| Shareholders' equity | ||||
| Retained earnings | -$33.7 | -$14.27 | -$44.49 | -$68.49 |
| Other shareholder equity | $2.5 | $7.34 | $1.54 | -$3.62 |
| Total shareholder equity | $940.56 | $946.13 | $895.95 | $441.8 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $291.99 | $291.63 | $291.08 | $299.9 |
| Cost of revenue | $193.43 | $194.88 | $191.68 | $190.53 |
| Gross Profit | $98.56 | $96.76 | $99.4 | $109.37 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $81.94 | $87.3 | $81.23 | $88.84 |
| Total operating expenses | $81.94 | $87.3 | $81.23 | $88.84 |
| Operating income | $16.62 | $9.46 | $18.17 | $20.54 |
| Income from continuing operations | ||||
| EBIT | $16.52 | $9.3 | $13.63 | $20.5 |
| Income tax expense | -$1.23 | -$2.27 | -$2.89 | $1.66 |
| Interest expense | $23.46 | $24.27 | $20.55 | $15.83 |
| Net income | ||||
| Net income | -$5.71 | -$12.7 | -$4.03 | $3.01 |
| Income (for common shares) | -$5.71 | -$12.7 | -$4.03 | $3.01 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1174.6 | $1121.29 | $1038.69 | $773.31 |
| Cost of revenue | $770.5 | $690.32 | $614.07 | $486.96 |
| Gross Profit | $404.1 | $430.97 | $424.62 | $286.35 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $339.31 | $338.99 | $320.39 | $250.29 |
| Total operating expenses | $339.31 | $338.99 | $320.39 | $250.29 |
| Operating income | $64.79 | $91.99 | $104.23 | $36.06 |
| Income from continuing operations | ||||
| EBIT | $59.96 | $78.42 | $93.95 | $35.82 |
| Income tax expense | -$4.73 | -$1.23 | $16.43 | -$3.23 |
| Interest expense | $84.11 | $49.44 | $53.51 | $61.53 |
| Net income | ||||
| Net income | -$19.43 | $30.21 | $24.01 | -$22.48 |
| Income (for common shares) | -$19.43 | $30.21 | $24.01 | -$22.48 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$5.71 | -$12.7 | -$4.03 | $3.01 |
| Operating activities | ||||
| Depreciation | $44.02 | $43.89 | $42.92 | $43.09 |
| Business acquisitions & disposals | -$1.35 | |||
| Stock-based compensation | $4.33 | $5.39 | $3.58 | $6.89 |
| Total cash flows from operations | $21.66 | $65.74 | $27.52 | $54.9 |
| Investing activities | ||||
| Capital expenditures | -$24.53 | -$18.82 | -$21.27 | -$17.83 |
| Investments | ||||
| Total cash flows from investing | -$25.97 | -$18.82 | -$21.27 | -$17.83 |
| Financing activities | ||||
| Dividends paid | -$0.32 | |||
| Sale and purchase of stock | $0.39 | -$3.19 | $1.63 | $0.47 |
| Net borrowings | -$5.15 | -$22.44 | -$12.14 | $1.85 |
| Total cash flows from financing | -$6.04 | -$25.75 | -$11.49 | -$28.19 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$10.35 | $21.17 | -$5.24 | $8.88 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$19.43 | $30.21 | $24.01 | -$22.48 |
| Operating activities | ||||
| Depreciation | $173.93 | $179.78 | $192.04 | $99.74 |
| Business acquisitions & disposals | -$1.35 | -$62.34 | -$676.88 | -$95.95 |
| Stock-based compensation | $20.19 | $18.77 | $13.96 | $10.33 |
| Total cash flows from operations | $169.82 | $199.78 | $210.32 | $137.93 |
| Investing activities | ||||
| Capital expenditures | -$82.45 | -$84.5 | -$57.26 | -$55.78 |
| Investments | ||||
| Total cash flows from investing | -$83.89 | -$146.86 | -$734.13 | -$151.73 |
| Financing activities | ||||
| Dividends paid | -$0.32 | -$0.91 | -$0.93 | -$1.14 |
| Sale and purchase of stock | -$0.7 | $3.1 | $399.85 | |
| Net borrowings | -$37.88 | -$108.83 | $8.48 | $221.99 |
| Total cash flows from financing | -$71.46 | -$121.66 | $391.64 | $220.31 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $14.46 | -$68.75 | -$132.18 | $206.5 |
News
Fundamentals
| Market cap | $1.37B |
|---|---|
| Enterprise value | $2.52B |
| Shares outstanding | 135.35M |
| Revenue | $1.17B |
|---|---|
| EBITDA | $233.89M |
| EBIT | $59.96M |
| Net Income | -$19.43M |
| Revenue Q/Q | 3.66% |
| Revenue Y/Y | 4.75% |
| P/E ratio | -70.38 |
|---|---|
| EV/Sales | 2.14 |
| EV/EBITDA | 10.76 |
| EV/EBIT | 41.96 |
| P/S ratio | 1.16 |
| P/B ratio | 1.46 |
| Book/Share | 6.93 |
| Cash/Share | 0.15 |
| EPS | -$0.14 |
|---|---|
| ROA | -0.80% |
| ROE | -2.05% |
| Debt/Equity | 1.55 |
|---|---|
| Net debt/EBITDA | 6.15 |
| Current ratio | 1.72 |
| Quick ratio | 1.34 |